STOCK TITAN

Intra-Cellular Therapies to Present at the Evercore ISI 3rd Annual HealthCONx Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq:ITCI) announced that CEO Sharon Mates, Ph.D., will participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on December 2, 2020, at 9:15 AM ET. Investors can access the live and archived webcast on the company’s Investor Relations website. Intra-Cellular Therapies is a biopharmaceutical firm focusing on developing innovative treatments for central nervous system disorders, leveraging insights from Nobel prize-winning research.

Positive
  • None.
Negative
  • None.

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on Wednesday, December 2, 2020 at 9:15am ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

CONTACT:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
jgrimaldi@burnsmc.com
212-213-0006


FAQ

What is the date and time of the fireside chat for Intra-Cellular Therapies?

The fireside chat is scheduled for December 2, 2020, at 9:15 AM ET.

Where can I watch the Intra-Cellular Therapies fireside chat?

The webcast can be accessed under 'Events & Presentations' on Intra-Cellular Therapies' Investor Relations website.

Who is participating in the fireside chat for Intra-Cellular Therapies?

Sharon Mates, Ph.D., the CEO and Chairman, will participate in the fireside chat.

What is the focus of Intra-Cellular Therapies?

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders.

What is the stock symbol for Intra-Cellular Therapies?

The stock symbol for Intra-Cellular Therapies is ITCI.

Intra-Cellular Therapies Inc.

NASDAQ:ITCI

ITCI Rankings

ITCI Latest News

ITCI Stock Data

8.87B
101.92M
2.33%
96.38%
1.72%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BEDMINSTER